Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Industry News U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 MillionGlobal Biodefense StaffMarch 25, 2026
Medical Countermeasures Mpox Antiviral Clinical Trial Advances as WHO Extends Global EmergencyGlobal Biodefense StaffJuly 17, 2025
Novel Class of Antimicrobials Shown Effective for NDM-1 Strains Antimicrobial Resistance August 2, 2013 …
